Black Diamond Therapeutics
BDTX
BDTX
102 hedge funds and large institutions have $308M invested in Black Diamond Therapeutics in 2021 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 41 increasing their positions, 13 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
102
Holders Change
-10
Holders Change %
-8.93%
% of All Funds
1.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
41
Reduced
13
Closed
34
Calls
$946K
Puts
$1.42M
Net Calls
-$470K
Net Calls Change
-$347K
Top Buyers
| 1 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$14.9M |
| 2 |
Morgan Stanley
New York
|
+$7.17M |
| 3 |
Two Sigma Investments
New York
|
+$3.55M |
| 4 |
SG Americas Securities
New York
|
+$3.36M |
| 5 |
BlackRock
New York
|
+$2.73M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$21.1M |
| 2 |
State Street
Boston,
Massachusetts
|
-$17.8M |
| 3 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$13.4M |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$10.7M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$8.74M |
